Publications by authors named "Roy M Matining"

Claim this Profile
W
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
Ayana E Morales, Ruby Gumenick, Caitlyn M Genovese, Yun Yeong Jang, Ariene Ouedraogo, Roy M Matining

PLoS Pathog· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS).
David L Wyles, Minhee Kang, Roy M Matining, Robert L Murphy, Marion G Peters

Open Forum Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
David L Wyles, Minhee Kang, Roy M Matining, Robert L Murphy, Marion G Peters

Open Forum Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Susan E Krown, Carlee B Moser, Patrick MacPhail, Roy M Matining, Catherine Godfrey

Lancet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
David L Wyles, Minhee Kang, Roy M Matining, Robert L Murphy, Marion G Peters

Open Forum Infect Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.
Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, Pablo Belaunzaran-Zamudio, Roy M Matining

AIDS Res Hum Retroviruses· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older age is associated with peripheral blood expansion of naïve B cells in HIV-infected subjects on antiretroviral therapy.
Puja Van Epps, Roy M Matining, Katherine Tassiopoulos, Donald D Anthony, Alan Landay

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.
Jeffrey M Jacobson, Lu Zheng, Cara C Wilson, Pablo Tebas, Roy M Matining

J Acquir Immune Defic Syndr· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.
Benigno Rodriguez, David M Asmuth, Roy M Matining, John Spritzler, Jeffrey M Jacobson

J Acquir Immune Defic Syndr· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy.
Babafemi Taiwo, Roy M Matining, Lu Zheng, Michael M Lederman, Charles R Rinaldo

J Antimicrob Chemother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.
Robert C Kalayjian, John Spritzler, Roy M Matining, Susan A Fiscus, Barry H Gross

AIDS· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).
Babafemi Taiwo, Lu Zheng, Sebastien Gallien, Roy M Matining, Daniel R Kuritzkes

AIDS· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis